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Abstract The environmental impact of nanoparticles is
evident; however, their toxicity due to their nanosize is
rarely discussed. Gold nanoparticles (GNPs) may serve as a
promising model to address the size-dependent biological
response to nanoparticles because they show good bio-
compatibility and their size can be controlled with great
precision during their chemical synthesis. Naked GNPs
ranging from 3 to 100 nm were injected intraperitoneally
into BALB/C mice at a dose of 8 mg/kg/week. GNPs of 3,
5, 50, and 100 nm did not show harmful effects; however,
GNPs ranging from 8 to 37 nm induced severe sickness in
mice. Mice injected with GNPs in this range showed fati-
gue, loss of appetite, change of fur color, and weight loss.
Starting from day 14, mice in this group exhibited a camel-
like back and crooked spine. The majority of mice in these
groups died within 21 days. Injection of 5 and 3 nm GNPs,
however, did not induce sickness or lethality in mice.
Pathological examination of the major organs of the mice
in the diseased groups indicated an increase of Kupffer
cells in the liver, loss of structural integrity in the lungs,
and diffusion of white pulp in the spleen. The pathological
abnormality was associated with the presence of gold
particles at the diseased sites, which were veriﬁed by ex
vivo Coherent anti-Stoke Raman scattering microscopy.
Modifying the surface of the GNPs by incorporating
immunogenic peptides ameliorated their toxicity. This
reduction in the toxicity is associated with an increase in
the ability to induce antibody response. The toxicity of
GNPs may be a fundamental determinant of the environ-
mental toxicity of nanoparticles.
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Introduction
The environmental impact of nanoparticles is evident;
however, their nanotoxicity due to the reduction in size to
nanoscale is rarely discussed. Gold nanoparticles (GNPs)
may serve as a promising model to address this size-depen-
dent toxicity, since gold is extraordinarily biocompatible.
Recently, the increased toxicity of nanoparticles due to
their tiny physical dimensions has been widely recognized
[1–3]. Carbon black is nontoxic; however, carbon nano-
tubes and fullerene are highly toxic when inhaled into the
lungs [4–6]. Similarly, enhanced toxicity of titanium oxide
nanoparticles has been reported [7, 8] and titanium oxide
nanoparticles have been shown to induce oxidative stress in
bacteria [9]. A large number of non-toxic bulk materials
become poisonous when their size is reduced to nanoscale.
However, the toxicity may be due more to the unique
surface chemistry of the individual nanoparticle and less to
the reduction in size per se.
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DOI 10.1007/s11671-009-9334-6The toxicity of GNPs has been investigated at the cel-
lular level. GNPs enter cells in a size- and shape-dependent
manner [10, 11]. Uptake of GNPs reaches a maximum
when the size nears 50 nm and when the aspect ratio
approaches unity. The transport efﬁciency reaches a pla-
teau 30 min after incubation. The uptake of GNPs is con-
sistent with receptor-mediated endocytosis. Nevertheless,
most GNPs can enter cells efﬁciently, and most studies
indicate that they are nearly harmless to cultured cells [12–
15].
We have previously shown that GNPs are capable of
inducing an antibody response in mice, which indicates that
factors other than cytotoxicity may be involved and com-
plicates in vivo application of GNPs [16]. The current
study is based on the hypothesis that the reduction in size
per se may make harmless GNPs toxic to live animals.
Materials and Methods
Materials
HAuCl4, sodium citrate, NaBH4, HCl, HNO3,H 2SO4,
H2O2, and other chemicals of analytical grade were pur-
chased from Sigma-Aldrich and Fisher. H2O was[18 MX
from a Milli-Q water puriﬁcation system.
Animals and Lethality Test
Animal treatments were performed following ‘‘The
Guidelines for the Care and Use of Experimental Animals’’
of National Chiao-Tung University. Four-week-old male
BALB/C mice were housed at 22 ± 2 C with a 12-h light/
dark cycle and fed standard rodent chow and water
ad libitum. Mice were randomly assigned to experimental
groups. Each group consisted of 6 mice. Administration of
GNPs was performed by intraperitoneal injection. Animals
were sacriﬁced at the end of experiment by cervical dis-
location. The liver, lung, brain, heart, and spleen were
isolated, and organ weights of all mice were measured.
Preparation of Gold Nanoparticles
Gold nanoparticles of diameter 3, 5, 8, 12, 17, 37, 50, and
100 nm were synthesized as reported previously [17, 18].
The seed colloids were prepared by adding 1 mL of
0.25 mM HAuCl4 to 90 mL of H2O and stirred for 1 min at
25 C. Two milliliters of 38.8 mM sodium citrate were
added to the solution and stirred for 1 min, followed by the
addition of 0.6 mL of freshly prepared 0.1 M NaBH4 in
38.8 mM sodium citrate. Different diameters of GNPs
ranging from 3 to 100 nm were generated by changing the
volume of seed colloid added. The solution was stirred for
an additional 5–10 min at 0–4 C. Reaction temperatures
and times were adjusted to obtain GNPs of larger size. All
synthesized GNPS were characterized by UV absorbance.
The size of synthesized GNPs was veriﬁed by electron
microscopy and atomic force microscopy. GNPs were
dialyzed against phosphate-buffered saline (pH 7.4) before
injection into the animals.
Enzyme-Linked Immunosorbent Assay (ELISA)
In order to coat wells with GNP as an antigen, each mi-
crowell of a 96-well Corning plate was pre-treated with
200 lL of 1 mM 3-aminopropyl-triethoxysilane (APTES)
in ethanol at room temperature for 40 min. The activated
wells were washed with ethanol twice for 5 min, followed
by distilled water for 5 min. GNPs (15 mM, 150 lL) were
added to the microwells and incubated for 2 h at room
temperature, followed by three Milli-Q water washes and
ﬁnally with three washes with 0.5% Triton X-100 in PBS.
To coat wells with other antigens, 100 lL of antigen was
added into microwells and incubated at room temperature
for 30 min, followed by three PBS washes. Blocking for
non-speciﬁc binding was performed by adding 100 lLo f
3% bovine serum albumin (BSA) and incubating for
60 min at room temperature, followed by three PBS
washes. Binding was performed by adding 100 lLo f
diluted antiserum into microwells and incubating for 1 h at
room temperature, followed by thorough washes. HRP-
conjugate anti-mouse IgG, 2,20-azino-di-(3-ethylbenz-
thiazoline sulfonic acid) (ABTS) and H2O2 were added in
sequence to the wells according to the manufacturer’s
protocol, and the binding efﬁciency was monitored by
measuring absorbance at 405 nm.
Ex Vivo Coherent Anti-Stoke Raman Scattering
(CARS) Microscopy
Freshly removed liver and lung tissues were dissected into
thin slices of approximately 2 mm in thickness and
immersed under PBS in a micro chamber on a glass slide
for examination. CARS microscopy was performed with a
time constant of 3 ms, a scanning area of 300 9 300 lm, a
step size of 1 lm, 300 9 300 pixels, a scanning velocity of
1 lm/ms, and a sampling rate of 80 kHz. Laser power was
set at 30 mW for 870 nm and 40 mW for 1064 nm. The
wavelengths of the pump and the Stokes lasers
(Pump = 870 nm and Stokes = 1064 nm) were tuned to
match a Raman shift (*2100 cm
-1) which falls in the so-
called ‘‘silent region’’ of the vibrational spectra of cells and
tissues. As expected, the CARS images of the ‘‘control’’
did not show appreciable contrast under the non-resonant
condition whereas the CARS signals were dramatically
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123enhanced—appearing as scattered bright spots on the
images taken from the GNPs-treated specimens. The
enhancement presumably resulted from strong scattering
by the GNPs and the large third-order polarizability of the
GNPs {Evans, 2005 #90}.
Surface Modiﬁcation of GNP
The highly immunogenic peptides pFMDV and pH5N1
were designed and synthesized based on viral protein 1 of
foot-and-mouth disease virus type O and matrix protein 2
of inﬂuenza A virus A/Hong Kong/482/97 H5N1, respec-
tively. The amino acid sequences are NGSSKYGDTSTN
NVRGDLQVLAQKAERTLC for pFMDV and MSLLTE
VETLTRNGWGCRCSDSSDC for pH5N1. An extra cys-
teine was added to the C-terminus of each peptide in order
to improve binding to the gold surface. BSA and lysozyme
were chosen to represent moderately immunogenic anti-
gens. Conjugation of antigen with 17 nm GNPs was per-
formed by titration the antigens into a GNP solution. The
titration was monitored by UV absorption at the wave-
length appropriate for each peptide to detect aggregation of
unsaturated GNP in the presence of 1 M sodium chloride.
After reaching the saturation point, the conjugated com-
plexes were puriﬁed by centrifugation and resuspended in
PBS to ﬁnal concentration of 0.3 mM.
Results and Discussion
GNPs Ranging from 8 to 37 nm Induced Severe
Sickness in Mice
GNPs were synthesized with diameters ranging from 3 to
100 nm according to published procedures [17, 18]. Syn-
thesis of GNPs was monitored by UV absorbance, and the
size was examined by electron microscopy (Fig. 1). The
puriﬁed GNPs had diameters of 3, 5, 8, 17, 12, 37, 50, and
100 nm. They were injected intraperitoneally into BALB/C
mice at a dose of 8 mg/kg/week. Mice injected with 3, 5,
50, and 100 nm GNPs behaved normally and survived
throughout the experimental period. Mice injected with 8,
17, 12, and 37 nm GNPs exhibited symptoms of toxicity.
The treated animals showed fatigue, loss of appetite,
change in fur color, and weight loss. There was a dramatic
difference in the fur color of GNP-treated mice compared
to the normal group, which was usually brownish. The skin
underneath had minor rashes, bruising, and hemorrhaging.
Starting from day 14, mice injected with 8–37 nm GNPs
showed a signiﬁcantly camel-like back and crooked spine.
The majority of mice in these groups died before the end of
the fourth week. The median survival time, deﬁned as the
length of time when half the mice died, was approximately
21 days for mice injected with 8–37 nm GNPs (Fig. 2).
Fig. 1 TEM images for the GNPs synthesized in the current study.
GNPs with diameters of 3, 5, 8, 12, 17, 37, 50, and 100 nm were
examined under an electron microscope. Scale bars are 20 nm for
images of 3, 5, 8, 12, and 17 nm GNPs. Scale bars are 50 nm for
images of 37, 50, and 100 nm GNPs
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Correlated with the Presence of GNPs in Organs
The acute symptoms and eventual death of mice receiving
GNPs indicated that the injected GNPs might damage
major organs. In the tissues samples stained with haema-
toxylin and eosin, the brain, heart, and kidney from 8 to
37 nm GNP-treated mice appeared indistinguishable from
tissues in control mice (data not shown). However, the
liver, lung, and spleen from 8 to 37 nm GNP-treated mice
showed various degrees of abnormality (Fig. 3).
For example, an increase of Kupffer cells (KCs) in the
liver was observed in GNP-treated mice. KCs constitute the
ﬁrst macrophage population of the host to come in contact
with bacteria, endotoxins, and microbial debris derived
from the gastrointestinal tract and transported to the liver.
KCs are an important component of the initial and rapid
response to potentially dangerous stimuli. Activation of
KCs suggested toxic potential for GNPs in this zone [19].
Quantitatively, signiﬁcant increase of KCs in the liver of
12, 17, and 37 nm GNP-treated mice was observed. Among
them, two-fold increase of KCs was observed in 37-nm
treated group. GNPs smaller than 8 nm (3 and 5 nm) or
larger than 37 nm (50 and 100 nm) did not induce signif-
icant KC variations in mouse livers.
Damage in lung tissue structure observed in GNP-trea-
ted mice appeared to be similar to that of emphysema. In
emphysema, the tiny air sacs (alveoli) in the lungs through
which oxygen is absorbed into the bloodstream lose their
natural elasticity. Emphysema is a progressive lung
condition that leaves sufferers struggling for breath, lead-
ing to fatigue, weight loss, and eventually death. Emphy-
sema-like structure was observed in the lung of 8, 12, 17,
and 37 nm GNP-treated mice. Other groups did not show
aberrant lung structure.
Signiﬁcant aberration of white pulp was observed in the
spleen from GNP-treated mice. The white pulp normally
consists of aggregates of lymphoid tissue and is responsible
for the immunological function of the spleen. White pulp
consisting of splenic nodules appeared diffused in the
experimental group. Diffused white pulps were observed in
the spleen of 8, 12, 17, and 37 nm GNP-treated mice. Other
groups did not show this aberration.
Contaminants of the GNP preparations, such as endo-
toxins, may have caused damage to organs leading to
death. However, all GNPs went through the same synthesis
and puriﬁcation procedure, but GNPs outside the lethal
range exhibited no toxic effects on mice. Furthermore, the
ELISA using anti-Gram negative endotoxin-IgG showed
negative results against all GNPs (Fig. 4). We can there-
fore exclude the possibility of endotoxin contamination as
an explanation for the toxic effects observed in the GNP-
treated mice.
It is possible that the abnormalities in the liver, lung, and
spleen of GNP-treated mice may have been the conse-
quence of direct contact with the invading GNPs. The
injected GNPs may have been transported through blood
veins or through diffusion into the liver, lung, and spleen.
Fig. 2 Average lifespan of mice receiving GNPs with diameters
between 8 and 37 nm was shortened to different extents. The average
lifespan (L50) was deﬁned as the time beyond which half of the mice
died. Mice injected with GNPs outside the lethal range behaved
normally. The break marks on the top of bars indicate no death
observed during the experimental period
Fig. 3 H&E staining showed GNP-induced abnormality in major
organs. (Top to bottom) HE staining for liver, lung, and spleen. The
left column shows tissues from 5 nm GNP-treated animals. The right
column shows tissues from 17 nm GNP-treated mice
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ex vivo CARS microscopy was performed on the freshly
dissected liver tissues [20] (Fig. 5). GNPs are known to
enhance the anti-Stoke Raman signal of nearby amino
acids. By applying proper controls, CARS microscopy can
detect GNPs by measuring this enhancement. Ex vivo
diffusion of GNPs into liver tissues was also performed to
verify the enhancement of the Raman signal. Localized
enhancement of the anti-Stroke Raman signal at an exci-
tation wavelength of 817 nm was observed for livers
removed from 8 to 37 nm GNP-treated mice. A signiﬁ-
cantly weaker signal was observed with livers from 50 nm
GNP-treated mice. The Raman signal was totally absent for
tissues from 5 nm GNP-treated mice, and tissues from the
control group showed no enhancement. The intensity of the
Raman signal in the CARS microscopy was proportional to
the severity of illness. Our evidence indicates that the
dysfunction of major organs is associated with the presence
of GNPs at the site of abnormality. Inductively coupled
plasma mass spectrometry (ICP-MS) is capable of deter-
mining the biodistribution of GNPs with different sizes.
Detailed biodistribution proﬁles could give more useful
information to explain the mechanism of toxicity [21–23].
Future experiments will be performed regarding this
method.
Fig. 4 ELISA of GNPs using anti-endotoxin IgG. ELISA was
performed by using anti-endotoxin IgG against various sizes of
GNPs synthesized in the lab. Lipopolysaccharide (LPS) served as a
positive control, while BSA served as a negative control
Fig. 5 CARS microscopy of
livers isolated from GNP-
treated and control mice. The
wavelengths of the pump and
the Stokes lasers
(Pump = 870 nm and
Stokes = 1064 nm) were tuned
to match a Raman shift
(*2100 cm
-1), falling in the
so-called ‘‘silent region’’ of the
vibrational spectra of cells and
tissues. As expected, the CARS
images of the ‘‘control’’ did not
show appreciable contrast under
the non-resonant condition
whereas the CARS signals were
dramatically enhanced and
appeared as scattered bright
spots on the images taken from
the specimens treated with
GNPs. The enhancement
presumably resulted from strong
scattering from the GNPs and
the large third-order
polarizability of the GNPs.
Enhanced bright spots were
observed in neither the control
group (a) nor the mice injected
with 5 nm GNP (b). Livers
obtained from 17 nm GNP-
treated mice showed intense
bright spots (c). Livers obtained
from 50 nm GNP-treated mice
showed only a moderate number
of spots (d)
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123Enhanced Immunogenicity Ameliorated the Harmful
Effect of GNPs
Study of GNP transport using Hela cells indicated that the
maximal endocytosis of GNPs occurs when the particles
have a diameter of 50 nm [11]. In the current study,
injection of 50 nm or larger GNPs, however, did not lead to
the death of mice, consistent with the observation that the
cell membrane prevents the passage of particles larger than
200 nm. In vivo aggregation of GNPs may have occurred
to increase the apparent particle size and lead to the
retardation of cellular uptake [24]. We observed that GNPs
smaller than 37 nm were lethal to mice, while a further
reduction to 5 nm was nontoxic. The alleviation of the
lethal effect for 3 and 5 nm GNPs remains to be explored.
It is possible that the difference in lethality may reﬂect a
difference in cellular toxicity. A colorimetric methyl-thia-
zol-tetrazolium (MTT) assay was performed to measure the
cytotoxicity of GNPs in cultured Hela cells. The viability
of cells exceeded 80% at the highest concentration of GNP
(0.4 mM), indicating that regardless of their size, all GNPs
were essentially non-toxic to Hela cells (Fig. 6). The
inconsistency of cytotoxicity and lethality indicated that
factors other than cytotoxicity may be involved in the
amelioration of the lethal effect for 3 and 5 nm GNPs.
We have previously shown that serum obtained from
mice injecting with 5 nm GNPs showed speciﬁc binding
activity to GNPs, while serum from mice immunized with
larger-sized GNPs showed only background binding [16].
This differential immune response of mice to different
sizes of GNPs indicates that the scavenging activity of the
immune system may play a role in the size-dependent
lethality of GNPs. To test this hypothesis, surface modiﬁ-
cation of 17 nm GNPs was carried out so that they would
display a spectrum of epitopes. The highly immunogenic
peptides pFMDV and pH5N1 were designed and synthe-
sized based on viral protein 1 of foot-and-mouth disease
virus type O and matrix protein 2 of inﬂuenza A virus (A/
Hong Kong/482/97(H5N1)), respectively. BSA and lyso-
zyme were selected to represent moderately immunogenic
antigens. As a positive control, mice were injected with
unmodiﬁed 17 nm GNPs. Injection of surface-modiﬁed
GNPs caused a spectrum of lethality in mice (Fig. 7).
pFMDV and pH5N1 conjugation extended the average
lifespan from 21 days to more than 50 days. Lysozyme
modiﬁcation elongated the lifespan to 27.5 days, while
BSA modiﬁcation caused elongation to 22.3 days. The titer
of antigen binding activity of sera was veriﬁed by ELISA
(Fig. 7). Sera obtained from groups injected with pFMDV
and pH5N1-conjugated 17 nm GNPs exhibited the highest
titer. Lysozyme- and BSA-coated GNPs induced moderate
titers. The ability of coated-GNPs to reduce the lethal
effect was closely associated with their ability to induce an
antibody response. In rodents, quantum dots with ﬁnal
hydrodynamic diameter \5.5 nm resulted in rapid and
efﬁcient urinary excretion and elimination from the body
[25]. Urinary secretion may play an important role to
remove GNPs under 5 nm in our model.
GNPs caused a range of lethality when injected into
mice. GNPs larger than 50 nm were nontoxic to mice,
which can be interpreted as a diffusion-restricted region.
The nontoxic effect of GNPs smaller than 5 nm can be
Fig. 6 MTT assay to obtain LC50 for different sizes of GNPs using
Hela cells as a model system. After seeding and proper attachment,
the Hela cells were treated with 5, 8, 12, and 17 nm GNPs at the
concentrations, indicated on the horizontal axis. The percentage of
survival was plotted against GNPs concentration
Fig. 7 The lethality and immunogenicity of surface-modiﬁed 17 nm
GNPs. Average lifespans of mice injected with modiﬁed 17 nm GNPs
are shown in empty columns. Each experimental group received GNP
conjugated with BSA, lysozyme, pFMDV, or pH5N1. Unmodiﬁed
GNPs served as a positive control (17 nm GNP). Titers of antiserum
withdrawn from GNP-injected mice against corresponding antigens
are shown in ﬁlled columns. pH5N1- and pFMDV-coated GNPs
induced the highest titer in mouse serum; BSA- and lysozyme-coated
GNPs induced a moderate titer; and unmodiﬁed GNPs did not induce
an antibody response in mice (*)
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enhanced the scavenging effect. Apparently, the lethal
effect is due to the inability of GNPs to stimulate a strong
immune response, which allows them to diffuse freely into
cells.
Conclusions
GNPs may exhibit low cellular toxicity in cultured cells.
Here, we show that given a sufﬁcient dose, the invasion of
seemingly nontoxic GNPs can have a lethal effect on mice.
Although the exact mechanism responsible for this lethal
effect is not clear at present, studies have suggested the
presence of GNPs at the diseased sites. While GNPs have
been widely used for targeting and imaging in drug
delivery, the toxicity due to their nanometer dimensions
must be a major concern. In addition to emphasizing this
toxicity, our study also provides an important basis for
studying the environmental toxicity of ﬁne particles.
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